Atara Biotherapeutics Inc (NASDAQ: ATRA): Stock That Needs Special Handling
Currently, there are 129.19M common shares owned by the public and among those 117.42M shares have been available to trade. Insiders at the company have transacted a total of 45 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Tomorrow Is Not Likely To Be Same For Atara Biotherapeutics Inc (ATRA)
Atara Biotherapeutics Inc (ATRA) concluded trading on Thursday at a closing price of $0.83, with 7.71 million shares of worth about $6.4 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -60.48% during that period and on Thursday, February 01 price saw a gain […]
These Numbers Could Change Investor Views For Atara Biotherapeutics Inc (NASDAQ: ATRA)
EcoR1 Capital, LLC recently announced the acquisition of new stake in Atara Biotherapeutics Inc (NASDAQ:ATRA). This fresh investment now brings its stake to 9.88% valued currently at $6.64 million. In addition, Wasatch Advisors, Inc. raised its holdings by 0.12 million to 8.4 million shares. And Redmile Group LLC has lifted its position by 3.85% or […]
Atara Biotherapeutics Inc (ATRA): Not A Time To Panic Nor Freeze
Atara Biotherapeutics Inc (ATRA) concluded trading on December 20, 2023 at a closing price of $0.55, with 3.73 million shares of worth about $2.05 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -68.19% during that period and On Wednesday the price saw a […]
